BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7451237)

  • 1. Sporadic Duchenne muscular dystrophy in females; genetic counseling of women with pelvifemoral muscular dystrophy.
    Zellweger H; Ionasescu V; Simpson J
    Helv Paediatr Acta; 1980 Sep; 35(4):343-8. PubMed ID: 7451237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA analysis and genetic counselling in Duchenne muscular dystrophy.
    Gardner RJ; Wilson SJ; Wilkins RJ
    N Z Med J; 1988 Jul; 101(849):455-7. PubMed ID: 3399183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
    Hutton EM; Thompson MW
    Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genotypic diagnosis of Duchenne and Becker muscular dystrophies].
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Ann Biol Clin (Paris); 1999; 57(4):417-26. PubMed ID: 10432364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis and modern management of Duchenne muscular dystrophy.
    Miller RG; Hoffman EP
    Neurol Clin; 1994 Nov; 12(4):699-725. PubMed ID: 7845338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
    Plauchu H; Dellamonica C; Cotte J; Robert JM
    J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of carriers of Duchenne muscular dystrophy: value of molecular analysis.
    LeRoy BS; Uhrhammer NA; Steere KJ; Boehm CD; King RA; Rich SS; Williams PP; Smith SA; de Martinville B
    Am J Med Genet; 1988 Nov; 31(3):709-21. PubMed ID: 2906525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with DNA analysis in Duchenne and Becker muscular dystrophy families in NSW.
    Morgan G; Donald JA; Chen J; Serravalle S; Colley P; Denton MJ
    Aust Paediatr J; 1988; 24 Suppl 1():98-9. PubMed ID: 3202741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier detection in Duchenne and Becker muscular dystrophy using dinucleotide repeat polymorphisms. A study in Mexican families.
    Arenas D; Coral R; Cisneros B; Peñaloza L; Salamanca F; Kofman S; Mercado R; Méndez J; Martínez C; Montañez C
    Arch Med Res; 1996; 27(2):151-6. PubMed ID: 8696057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic counseling in progressive muscular dystrophy].
    Hemke G; Szibor R; Braun H
    Beitr Orthop Traumatol; 1975 Jan; 22(1):28-9. PubMed ID: 1122231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling issues in the use of DNA analysis for Duchenne/Becker muscular dystrophy.
    Cortada JM; Milsark I; Richards CS
    Birth Defects Orig Artic Ser; 1990; 26(3):231-7. PubMed ID: 2092850
    [No Abstract]   [Full Text] [Related]  

  • 15. [New aspects of carrier diagnosis and human genetic counseling in Duchenne and Becker muscular dystrophy].
    Spiegler AW; Huppert P; Werner W; Metzke H; Strobel U; Köhler K; Gerhardt R; Kaufmann J; Herrmann FH
    Z Arztl Fortbild (Jena); 1988; 82(22):1139-42. PubMed ID: 3247797
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential pitfalls in using DNA probes to counsel Duchenne and Becker muscular dystrophy families.
    Shi YJ; Fischbeck KH; Ritter A
    Chin Med J (Engl); 1992 Jun; 105(6):469-75. PubMed ID: 1451547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg-Welander syndrome.
    Wood S; Shukin RJ; McGillivray BC; Ray PN; Worton RG
    Am J Med Genet; 1988 Feb; 29(2):419-23. PubMed ID: 2895584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
    Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
    Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection and prenatal diagnosis of Duchenne/Becker muscular dystrophy (D/BMD) by DNA-analysis.
    Bakker E; Bonten EJ; den Dunnen JT; Veenema H; Grootscholten PM; van Ommen GJ; Pearson PL
    Prog Clin Biol Res; 1989; 306():51-67. PubMed ID: 2662213
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular analysis of the Duchenne muscular dystrophy gene in Spanish individuals: deletion detection and familial diagnosis.
    Patiño A; Narbona J; García-Delgado M
    Am J Med Genet; 1995 Nov; 59(2):182-7. PubMed ID: 8588583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.